Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze HALO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate HALO investment potential.

What is HALO stock price today?

Get real-time HALO stock price, historical data, and price charts on Financhill. Track HALO performance with our advanced analysis tools.

Is HALO a good investment?

Evaluate HALO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy HALO stock?

To buy HALO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of HALO?

View detailed market capitalization data and company valuation metrics for HALO on our comprehensive analysis page.

What is the P/E ratio of HALO?

Use our fundamental analysis tools to view HALO P/E ratio and compare valuation metrics with industry peers.

What are HALO earnings?

View HALO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Halozyme Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

HALO
Halozyme Therapeutics, Inc.

Last Price:

$63.57

Seasonality Move:

2.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Halozyme Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Halozyme Therapeutics, Inc. has on average historically risen by 30.6% based on the past 21 years of stock performance.
Halozyme Therapeutics, Inc. has risen higher in 14 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is Halozyme Therapeutics, Inc. Stock Undervalued?

The current Halozyme Therapeutics, Inc. [HALO] share price is $66.48. The Score for HALO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Halozyme Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Halozyme Therapeutics, Inc. has on average historically risen by 30.6% based on the past 21 years of stock performance.

Halozyme Therapeutics, Inc. Stock Rating

Sell

Halozyme Therapeutics, Inc. (HALO) is a Sell

Is Halozyme Therapeutics, Inc. overpriced?

Halozyme Therapeutics, Inc. has risen higher in 14 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Halozyme Therapeutics, Inc. Stock Price History

Is HALO stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

halozyme.com

52-Week Data

52-Week High:

82.22

52-Week Low:

47.50

Prediction Charts

Market Cap:

7.8B

Price in USD:

66.48

Volume:

1.5M

Beta:

1.41

Technical Analysis

SMA50:

72.35

SMA100:

69.77

SMA200:

66.57

52-Wk Change:

8.19%

Stock Predictions

Is Halozyme Therapeutics, Inc. stock public?

Yes, Halozyme Therapeutics, Inc. is a publicly traded company.
What is the Halozyme Therapeutics, Inc. stock quote today?

The Halozyme Therapeutics, Inc. stock price is 66.48 USD today.
How to buy Halozyme Therapeutics, Inc. stock online?

You can buy Halozyme Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Feb-20	71.71	70.98	72.72	70.56
Feb-23	70.66	70.64	71.33	69.80
Feb-24	70.48	70.36	71.39	70.15
Feb-25	70.25	70.35	70.74	69.13
Feb-26	70.29	69.22	70.29	68.38
Feb-27	68.87	69.53	69.95	68.23
Mar-2	69.05	69.85	70.68	68.02
Mar-3	68.47	69.40	69.61	68.12
Mar-4	69.68	70.02	71.53	69.38
Mar-5	69.12	67.36	69.51	66.47
Mar-6	66.80	67.37	68.00	66.26
Mar-9	66.95	68.14	68.35	66.05
Mar-10	68.22	67.81	68.40	67.14
Mar-11	67.31	66.48	67.63	66.26

Halozyme Therapeutics, Inc. Earnings

Halozyme Therapeutics, Inc. Earnings Report: Per Share Halozyme Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Halozyme Therapeutics, Inc. Forecast Revenue Growth

Halozyme Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Halozyme Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.02 per share, an increase this year of $1.46 per share, and an increase next year of $1.83 per share.

* Halozyme Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.